
Myeloproliferative Neoplasms
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
This book focuses on three of the main categories of myeloproliferative neoplasm: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Relevant laboratory and clinical advances are comprehensively covered, and great emphasis is placed on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic approaches, the value and limitations of mutation screening for diagnostic and prognostic purposes, risk stratification in terms of both survival and other disease complications such as leukemic transformation and thrombosis, and modern therapeutic strategies, including conventional drugs, allogeneic stem cell transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field. von Barbui, Tiziano und Tefferi, Ayalew
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
The discovery of the JAK2 V617F mutation in the majority of patients with bcr/abl-negative myeloproliferative neoplasms has stimulated a number of questions regarding the diagnosis, prognosis, and treatment of polycythemia vera, essential thrombocythemia, and primary myelofibrosis. This book provides evidence-based reviews and expert consensus results concerning the key clinical issues for patient management. Practical recommendations are provided for the optimization and standardization of management of all three types of myeloproliferative neoplasm. Risk stratification, treatment goals, and first- and second-line therapies are discussed in detail, and other relevant diagnostic and research issues are also addressed. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field.
- Kartoniert
- 480 Seiten
- Erschienen 2021
- Dark Horse Books
- paperback
- 342 Seiten
- Erschienen 2016
- Tilted Windmill Press
- hardcover
- 416 Seiten
- Erschienen 2013
- INK
- Kartoniert
- 428 Seiten
- Erschienen 2008
- Thieme
- paperback
- 308 Seiten
- Erschienen 2023
- Moreland Books Inc
- paperback
- 312 Seiten
- Erschienen 2017
- Tektime
- hardcover
- 421 Seiten
- Erschienen 2005
- Ace Books
- paperback
- 320 Seiten
- Erschienen 2016
- HarperCollins
- paperback
- 544 Seiten
- Erschienen 2014
- LYX
- Kartoniert
- 152 Seiten
- Erschienen 2021
- Marvel Universe
- Kartoniert
- 432 Seiten
- Erschienen 2018
- Heyne Verlag
- Kartoniert
- 128 Seiten
- Erschienen 2018
- Panini Verlags GmbH
- paperback
- 320 Seiten
- Erschienen 2024
- Neptun Verlag